USFDA to review Sanofi isatuximab for treatment of multiple myeloma Medical Dialogues Bureau21 July 2019 9:15 AM ISTSanofi Isatuximab targets a specific epitope on the CD38 receptor. It is designed to trigger multiple, distinct mechanisms of action that are believed...